Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - OPERATING EXPENSES
Operating Expenses HALO - Halozyme Therapeutics, Inc.
304 M
LAST VALUE
9.63%
2 YEAR CAGR
6.90%
5 YEAR CAGR
10.16%
10 YEAR CAGR